Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.69 | 9.76 |
| PEG Ratio (TTM) | -0.57 | 5.08 |
| P/S Ratio (TTM) | 0.32 | 1.10 |
| P/B Ratio (TTM) | 0.67 | 16.31 |
| P/FCF Ratio (TTM) | 25.79 | 10.68 |
| Price to 5YR AVG Earnings Ratio | -7.97 | 13.33 |
| Price to 5YR AVG FCF Ratio | 40.79 | 10.44 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.47% | 2.40% |
| ROE (TTM) | -10.06% | -2.50% |
| Net Profit Margin (TTM) | -4.77% | 1.93% |
| ROIC 5YR AVG | -0.48% | 13.87% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 178.72% | -1,652.10% | -1,042.17% |
| Revenue | 2.54% | -12.63% | -4.05% |
| Net Income | 182.96% | -1,663.78% | -1,050.40% |
| Cash Flow | 875.79% | 66.45% | 45.32% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.69 | 1.84 |
| Quick Ratio (TTM) | 1.09 | 1.21 |
| D/E Ratio (TTM) | 1.04 | 30.55 |
| Interest Coverage (TTM) | 0.44 | 66.49 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 1.30 | 2.03 |
| LTL to 5YR AVG FCF | 59.97 | 7.32 |
| Shares Outstanding Growth 5YR AVG | 0.46% | -0.47% |